Future endeavors should aim to bridge the existing gaps in knowledge, with a particular focus on unraveling the complexities of the TME and exploring novel combinations of therapeutic modalities to improve patient outcomes in the fight against KRAS-mutant cancers. This evidence concerns the gene KRAS and cancer.